Abnormal expression of ANXA2 predicts cholangiocarcinoma's poor prognosis and exacerbates malignancy via activating β-catenin signaling

Subjects

Subjects :

Poor prognosis
Hepatology
business.industry
Gastroenterology
medicine
Cancer research
β catenin signaling
Abnormal expression
Malignancy
medicine.disease
business

Details

ISSN :

1365182X

Volume :

20

Database :

OpenAIRE

Journal :

HPB

Accession number :

edsair.doi...........01c68ce81648a3960d4f36b7f1d9874a

Full Text :

https://doi.org/10.1016/j.hpb.2018.06.1354